Aurinia Pharmaceuticals (AUPH) Inventory Average (2021 - 2026)

Aurinia Pharmaceuticals has reported Inventory Average for 6 years, with the latest figure at $46.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 7.82% year-over-year to $46.0 million; the trailing twelve-month figure through Mar 2026 stood at $46.0 million (up 7.82% YoY), and the FY2025 full-year result was $42.5 million, up 7.58% from the prior year.
• Inventory Average for Q1 2026 stood at $46.0 million, up from $45.2 million in the prior quarter.
• The five-year high for Inventory Average was $46.3 million in Q2 2025, with the low at $22.8 million in Q1 2022.
• Historically, Inventory Average has averaged $36.0 million across 5 years, with a median of $38.8 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average soared 56.49% — and 2024, when it gained 7.47%.
• Aurinia Pharmaceuticals' Inventory Average stood at $25.0 million in 2022, then soared by 44.84% to $36.3 million in 2023, then advanced by 7.47% to $39.0 million in 2024, then rose by 16.09% to $45.2 million in 2025, then advanced by 1.79% to $46.0 million in 2026.
• The last three Inventory Average figures came in at $46.0 million (Q1 2026), $45.2 million (Q4 2025), and $45.6 million (Q3 2025), per Business Quant data.